Webster Bank N. A. Raises Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Webster Bank N. A. boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 87.7% during the second quarter, Holdings Channel.com reports. The firm owned 321 shares of the medical equipment provider’s stock after acquiring an additional 150 shares during the quarter. Webster Bank N. A.’s holdings in Intuitive Surgical were worth $143,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in ISRG. Norges Bank bought a new position in Intuitive Surgical during the 4th quarter valued at approximately $1,313,238,000. WCM Investment Management LLC bought a new stake in Intuitive Surgical in the fourth quarter worth $575,536,000. Capital Research Global Investors purchased a new stake in shares of Intuitive Surgical in the first quarter worth $374,390,000. Assenagon Asset Management S.A. increased its holdings in shares of Intuitive Surgical by 111.7% during the first quarter. Assenagon Asset Management S.A. now owns 1,285,565 shares of the medical equipment provider’s stock valued at $513,056,000 after acquiring an additional 678,375 shares in the last quarter. Finally, Coatue Management LLC raised its position in shares of Intuitive Surgical by 65.7% in the 4th quarter. Coatue Management LLC now owns 1,301,595 shares of the medical equipment provider’s stock worth $439,106,000 after purchasing an additional 516,054 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.0 %

Intuitive Surgical stock traded down $0.19 during midday trading on Friday, hitting $463.43. The stock had a trading volume of 1,022,572 shares, compared to its average volume of 1,568,958. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $468.78. The company has a market capitalization of $164.38 billion, a PE ratio of 83.65, a P/E/G ratio of 4.97 and a beta of 1.39. The firm’s fifty day moving average is $437.17 and its two-hundred day moving average is $404.25.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating the consensus estimate of $1.54 by $0.24. The firm had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The company’s revenue was up 14.5% on a year-over-year basis. During the same period last year, the firm earned $1.18 EPS. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Craig H. Barratt sold 2,496 shares of the business’s stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $402.89, for a total value of $1,005,613.44. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other news, EVP Robert Desantis sold 284 shares of the firm’s stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $389.16, for a total transaction of $110,521.44. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,142,714.96. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Craig H. Barratt sold 2,496 shares of the business’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $402.89, for a total value of $1,005,613.44. The disclosure for this sale can be found here. Insiders have sold 15,766 shares of company stock worth $6,802,276 over the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have weighed in on ISRG. Stifel Nicolaus raised their price objective on shares of Intuitive Surgical from $430.00 to $475.00 and gave the company a “buy” rating in a research note on Friday, July 19th. Piper Sandler boosted their price objective on shares of Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a report on Friday, July 19th. Evercore ISI cut their target price on Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating on the stock in a research note on Friday, July 19th. The Goldman Sachs Group started coverage on Intuitive Surgical in a research note on Thursday, May 30th. They issued a “buy” rating and a $500.00 price target for the company. Finally, Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their price objective for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. Six equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $442.30.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.